公司资料
Armata Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- ARMP
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
5.10 USD (+15.38%)
收盘价
最后更新: 2026年8月21日
291M USD
市值
股价为何变动
As of Aug 21, 2026, ARMP closed up 15.4% at $5.10. No new same-company headline was identified in the current news window.
公司概览
业务概览
Armata Pharmaceuticals is a bacteriophage company focused on precision therapies for bacterial infections. Its platform aims to use phage biology to address resistant pathogens.
所在地与行业分类
Headquartered in the United States and listed on NYSE American, Armata sits in specialty biotechnology.
商业模式特征
The company depends on clinical data, anti-infective differentiation, and the ability to build a durable phage-therapy story.
生物医药行业定位
Armata is a niche anti-infective catalyst name whose valuation depends on development progress.
未来催化剂
- Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing. The market will care about whether the clinical path stays open.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。